论文部分内容阅读
目的:对贝那普利联合美托洛尔治疗扩张型心肌病心力衰竭的临床效果进行分析研究,以供参考。方法:本次研究对象,为我院2016年至2017年期间,接受治疗的50例扩张型心肌病心力衰竭患者,对参与研究患者随机分组,对照组患者使用贝那普利进行治疗,研究组患者则使用贝那普利联合美托洛尔进行治疗,对两组患者的心功能指标以及治疗效果进行对比研究。结果:研究组患者的心功能指标以及治疗效果明显优于对照组患者。P<0.05认为差异具有统计学意义。结论:在对扩张型心肌病心力衰竭患者的治疗工作中,对患者使用贝那普利联合美托洛尔进行治疗,可有效改善患者的心功能,具有较高的临床研究价值。
Objective: To analyze the clinical effect of benazepril combined with metoprolol in the treatment of dilated cardiomyopathy heart failure for reference. Methods: The study was conducted in 50 patients with dilated cardiomyopathy and heart failure admitted to our hospital from 2016 to 2017. Patients in the study group were randomly assigned to receive treatment with benazepril. The study group Patients were treated with benazepril combined with metoprolol to compare cardiac function and treatment outcomes between the two groups. Results: The cardiac function index and the treatment effect of the study group were significantly better than those of the control group. P <0.05 considered that the difference was statistically significant. Conclusions: In the treatment of patients with heart failure due to dilated cardiomyopathy, the use of benazepril combined with metoprolol for treatment of patients with heart failure can effectively improve the patient’s cardiac function and has high clinical value.